LLY

966.35

+1.98%↑

JNJ

221.39

+0.12%↑

ABBV

202.82

+0.84%↑

UNH

384.32

+1.29%↑

AZN

181.82

-0.27%↓

LLY

966.35

+1.98%↑

JNJ

221.39

+0.12%↑

ABBV

202.82

+0.84%↑

UNH

384.32

+1.29%↑

AZN

181.82

-0.27%↓

LLY

966.35

+1.98%↑

JNJ

221.39

+0.12%↑

ABBV

202.82

+0.84%↑

UNH

384.32

+1.29%↑

AZN

181.82

-0.27%↓

LLY

966.35

+1.98%↑

JNJ

221.39

+0.12%↑

ABBV

202.82

+0.84%↑

UNH

384.32

+1.29%↑

AZN

181.82

-0.27%↓

LLY

966.35

+1.98%↑

JNJ

221.39

+0.12%↑

ABBV

202.82

+0.84%↑

UNH

384.32

+1.29%↑

AZN

181.82

-0.27%↓

Home・Listă Acțiuni・Abbott Laboratories

Abbott Laboratories

Închisă

SectorSănătate

82.56 -1.99

Cumpără Vinde

Rezumat

Modificarea prețului

24h

Curent

Minim

81.97

Maxim

84.41

Indicatori cheie
By Trading Economics
Venit	-699M 1.1B
Vânzări	-295M 11B
P/E Medie Sector	25.083 49.8
EPS	1.15
Randament dividend	2.73
Marjă de profit	9.647
Angajați	122,000
EBITDA	-980M 1.8B

Recomandări
By TipRanks
Recomandări	Puternic Cumpărare
Prognoză pe 12 luni	+42.6% upside

Dividende
By Dow Jones
Randament dividend Medie Sector	2.73% 2.25%
Următoarele câștiguri	16 iul. 2026
Data viitoare de dividende	15 mai 2026
Următoarea dată ex-dividende	14 iul. 2026

Statistici piață
By TradingEconomics
Capitalizare de piață	-22B 152B
Deschiderea anterioară	84.55
Închiderea anterioară	82.56

Sentimentul știrilor

By Acuity

33%

67%

116 / 346 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Weak Bullish Evidence

132.82 / 134.43 Suport & Rezistență

Abbott Laboratories Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

16 apr. 2026, 15:13 UTC

Câștiguri

Principalele dinamici ale pieței

Abbott Laboratories Cuts Outlook, Says Mild Flu Season Hurt 1Q Sales -- Update

16 apr. 2026, 12:23 UTC

Câștiguri

Principalele dinamici ale pieței

Abbott Laboratories Cuts Outlook, Narrows 1Q Profit

22 ian. 2026, 18:36 UTC

Câștiguri

Principalele dinamici ale pieței

Abbott Laboratories Raised Prices, Prompting Sales Slump -- Update

22 ian. 2026, 13:23 UTC

Câștiguri

Principalele dinamici ale pieței

Abbott Laboratories 4Q Sales Grow, Outlook Underwhelms

16 apr. 2026, 20:23 UTC

Câștiguri

These Stocks Are Today's Movers: AMD, Intel, TSMC, Abbott, Hims, Corning, Schwab, Polaris, and More -- Barrons.com

16 apr. 2026, 16:15 UTC

Câștiguri

These Stocks Are Today's Movers: AMD, Intel, TSMC, Abbott, Hims, Corning, Schwab, Polaris, and More -- Barrons.com

16 apr. 2026, 14:00 UTC

Market Talk

Câștiguri

A Mild Flu Season Hurt Abbott's Recent Quarter -- Market Talk

16 apr. 2026, 13:59 UTC

Market Talk

Câștiguri

Abbott Laboratories Has Disappointing Quarter -- Market Talk

16 apr. 2026, 12:05 UTC

Câștiguri

Achiziții, Fuziuni, Preluări

Abbott Stock Tumbles on Earnings. Nutrition Business Is Struggling and Merger Costs Biting. -- Barrons.com

16 apr. 2026, 11:32 UTC

Câștiguri

Achiziții, Fuziuni, Preluări

Abbott Labs: 2026 EPS View Includes 20c Dilution Related to Exact Sciences Buy >ABT

16 apr. 2026, 11:30 UTC

Câștiguri

Achiziții, Fuziuni, Preluări

Abbott Labs Sees 2Q Adj EPS $1.25-Adj EPS $1.31 >ABT

16 apr. 2026, 11:30 UTC

Câștiguri

Achiziții, Fuziuni, Preluări

Abbott Labs Sees 2026 Comparable Sales Growth of 6.5%-7.5% >ABT

16 apr. 2026, 11:30 UTC

Câștiguri

Achiziții, Fuziuni, Preluări

Abbott Labs Updates Guidance to Reflect Acquisition of Exact Sciences >ABT

16 apr. 2026, 11:30 UTC

Câștiguri

Achiziții, Fuziuni, Preluări

Abbott Labs 1Q Sales $11.16B >ABT

16 apr. 2026, 11:30 UTC

Câștiguri

Achiziții, Fuziuni, Preluări

Abbott Reports First-Quarter 2026 Results; Updates Guidance To Reflect Acquisition Of Exact Sciences >ABT

16 apr. 2026, 11:30 UTC

Câștiguri

Achiziții, Fuziuni, Preluări

Abbott Labs 1Q Net $1.08B >ABT

16 apr. 2026, 11:30 UTC

Câștiguri

Achiziții, Fuziuni, Preluări

Abbott Labs 1Q Adj EPS $1.15 >ABT

16 apr. 2026, 11:30 UTC

Câștiguri

Achiziții, Fuziuni, Preluări

Abbott Labs Sees FY Adj EPS $5.38-Adj EPS $5.58 >ABT

16 apr. 2026, 11:30 UTC

Câștiguri

Achiziții, Fuziuni, Preluări

Abbott Labs 1Q EPS 61c >ABT

11 apr. 2026, 00:00 UTC

Câștiguri

Achiziții, Fuziuni, Preluări

Big Yachts, Big Bucks -- Barrons.com

23 mar. 2026, 12:50 UTC

Achiziții, Fuziuni, Preluări

Abbott Completes Acquisition Of Exact Sciences >ABT

20 mar. 2026, 13:01 UTC

Achiziții, Fuziuni, Preluări

Abbott Labs: Received All Regulatory Clearances for Exact Sciences Buy >ABT EXAS

20 mar. 2026, 13:00 UTC

Achiziții, Fuziuni, Preluări

Abbott Acquisition Of Exact Sciences Set To Close On March 23, 2026 >ABT

28 ian. 2026, 14:48 UTC

Câștiguri

Abbott Stock Fell the Most in 23 Years After Earnings. The CEO Bought $2 Million of Shares. -- Barrons.com

23 ian. 2026, 16:59 UTC

Câștiguri

Correction to Abbott Stock Drops Article on Jan. 22

22 ian. 2026, 20:42 UTC

Câștiguri

Abbott Stock Is on Pace for Worst Day Since 2000. The Nutrition Business Is a Drag on Earnings. -- Barrons.com

22 ian. 2026, 16:19 UTC

Câștiguri

Abbott Stock Slumps. The Nutrition Business Is a Drag on Earnings. -- Barrons.com

22 ian. 2026, 15:22 UTC

Câștiguri

Abbott Stock Drops on Slumping Sales of Baby Formula and Nutrition Shakes -- WSJ

22 ian. 2026, 14:41 UTC

Acțiuni populare

Stocks to Watch Thursday: Intel, P&G, GE Aerospace -- WSJ

22 ian. 2026, 14:08 UTC

Market Talk

Câștiguri

Abbott Posts Disappointing 4Q -- Market Talk

Comparație

Modificare preț

Abbott Laboratories Așteptări

Obiectiv de preț

By TipRanks

42.6% sus

Prognoză pe 12 luni

Medie 120.24 USD 42.6%

Maxim 143 USD

Minim 92 USD

În baza a 20 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruAbbott Laboratories - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

20 ratings

Cumpărare

Păstrare

Vânzare

Ținând cont de 20 analiști care au acordat evaluări ale acțiunilor Abbott Laboratories - Dist în ultimele 3 luni.

Scor tehnic

By Trading Central

132.82 / 134.43Suport & Rezistență

Bullish events outweigh bearish events.

The bullish and bearish events are balanced.

All events are bullish.

Sentiment

By Acuity

116 / 346 Clasament în Sănătate

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

Despre Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.